Compounds > tobramycin
Page last updated: 2024-08-23

tobramycin and Cough

tobramycin has been researched along with Cough in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albasri, M; Andrinopoulou, ER; Arets, HGM; Heijerman, HGM; Majoor, CJ; Meerburg, JJ; Tiddens, HAWM; van der Eerden, MM; van der Wiel, EC1
Angyalosi, G; Cao, W; Debonnett, L; Sommerwerck, U; Viegas, A; Virella-Lowell, I1
Angyalosi, G; Brockhaus, F; Chiron, R; Flume, PA; Geller, DE; He, E; Higgins, M; Kappler, M; Konstan, MW; Zhang, J1
Geller, DE; Kissner, DG; McColley, SA; McKevitt, M; Montgomery, AB; Moorehead, L; Rolfe, MW; Rosen, JM; Trapnell, BC1
Anbar, RD; Colin, AA; Lester, LA; Murphy, TD; Nasr, SZ; Nickerson, B; VanDevanter, DR1
Conrad, C; Geller, DE; Konstan, MW; Noonberg, SB; Smith, J1

Trials

5 trial(s) available for tobramycin and Cough

ArticleYear
Long-term safety of tobramycin inhalation powder in patients with cystic fibrosis: phase IV (ETOILES) study.
    Current medical research and opinion, 2016, Volume: 32, Issue:11

    Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Cough; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Male; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2016
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2011, Volume: 10, Issue:1

    Topics: Administration, Inhalation; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Cough; Cystic Fibrosis; Drug Administration Schedule; Drug Delivery Systems; Drug Monitoring; Dry Powder Inhalers; Female; Humans; Male; Middle Aged; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Sputum; Tobramycin; Treatment Outcome

2011
Fosfomycin/tobramycin for inhalation in patients with cystic fibrosis with pseudomonas airway infection.
    American journal of respiratory and critical care medicine, 2012, Jan-15, Volume: 185, Issue:2

    Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Cough; Cystic Fibrosis; Double-Blind Method; Drug Combinations; Female; Forced Expiratory Volume; Fosfomycin; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Tobramycin; Treatment Outcome; United States

2012
Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease.
    Pediatric pulmonology, 2004, Volume: 38, Issue:4

    Topics: Administration, Inhalation; Adolescent; Anti-Bacterial Agents; Child; Cough; Cystic Fibrosis; Female; Fever; Hospitalization; Humans; Lung Diseases; Male; Survival Analysis; Survival Rate; Time Factors; Tobramycin; Treatment Outcome

2004
Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
    Pediatric pulmonology, 2007, Volume: 42, Issue:4

    Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Child; Cough; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysgeusia; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Opportunistic Infections; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tobramycin

2007

Other Studies

1 other study(ies) available for tobramycin and Cough

ArticleYear
Home videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and cough.
    Pediatric pulmonology, 2019, Volume: 54, Issue:11

    Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Child; Cough; Cystic Fibrosis; Female; Humans; Male; Powders; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Tobramycin; Video Recording; Young Adult

2019